<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.SC updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.SC</link>
    <description>q-bio.SC updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.SC" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Thu, 09 Oct 2025 01:50:41 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Wed, 08 Oct 2025 00:00:00 -0400</pubDate>
    <skipDays>
      <day>Saturday</day>
      <day>Sunday</day>
    </skipDays>
    <item>
      <title>Deciphering the Role of Acetate in Metabolic Adaptation and Osimertinib Resistance in Non-Small Cell Lung Cancer</title>
      <link>https://arxiv.org/abs/2510.05920</link>
      <description>arXiv:2510.05920v1 Announce Type: new 
Abstract: Aims. Resistance to targeted therapies remains a major challenge in EGFR-mutant non-small cell lung cancer (NSCLC). Here, we describe a novel metabolic adaptation in osimertinib-resistant cells characterized by elevated acetate levels and activation of an unconventional pyruvate-acetaldehyde-acetate (PAA) shunt. Methods. Integrated transcriptomic, exometabolomic, and functional analyses reveal suppression of canonical metabolic pathways and upregulation of ALDH2 and ALDH7A1, that mediate the NADP+-dependent oxidation of acetaldehyde to acetate, generating NADPH. Results. This shift generates reducing power essential for biosynthesis and redox balance under conditions of oxidative pentose phosphate inhibition. These metabolic changes promote endurance in resistant cells and rewire the interplay between glycolysis, the pentose phosphate pathway, and the tricarboxylic acid cycle, offering a de novo bypass for anaplerosis and bioenergetics. Systematic metabolite profiling revealed distinct transcriptomic and metabolic signatures distinguishing resistant from drug sensitive parental cells. Conclusions. Together, these findings depict a unique, resistance-driven adaptive metabolic shift and uncover potential therapeutic vulnerabilities in osimertinib-resistant NSCLC.</description>
      <guid isPermaLink="false">oai:arXiv.org:2510.05920v1</guid>
      <category>q-bio.SC</category>
      <category>q-bio.CB</category>
      <pubDate>Wed, 08 Oct 2025 00:00:00 -0400</pubDate>
      <arxiv:announce_type>new</arxiv:announce_type>
      <dc:rights>http://arxiv.org/licenses/nonexclusive-distrib/1.0/</dc:rights>
      <dc:creator>Giorgia Maroni (Consiglio Nazionale delle Ricerche, Istituto di Tecnologie Biomediche ITB CNR, Pisa, Italy), Eva Cabrera San Millan (Consiglio Nazionale delle Ricerche, Istituto di Tecnologie Biomediche ITB CNR, Pisa, Italy), Beatrice Campanella (Istituto di Chimica dei Composti Organo Metallici ICCOM CNR Pisa, Italy), Massimo Onor (Istituto di Chimica dei Composti Organo Metallici ICCOM CNR Pisa, Italy), Giovanni Cercignani (Scuola Normale di Pisa, Class of Sciences, Pisa, Italy), Beatrice Muscatello (Dipartimento di Farmacia, University of Pisa and CISUP, Pisa, Italy), Giulia Braccini (Consiglio Nazionale delle Ricerche, Istituto di Tecnologie Biomediche ITB CNR, Pisa, Italy), Raffaella Mercatelli (Consiglio Nazionale delle Ricerche, Istituto di Tecnologie Biomediche ITB CNR, Pisa, Italy), Alice Chiodi (Consiglio Nazionale delle Ricerche, Istituto di Tecnologie Biomediche ITB CNR, Pisa, Italy), Ettore Mosca (Consiglio Nazionale delle Ricerche, Istituto di Tecnologie Biomediche ITB CNR, Pisa, Italy), Elena Levantini (Consiglio Nazionale delle Ricerche, Istituto di Tecnologie Biomediche ITB CNR, Pisa, Italy), Emilia Bramanti (Istituto di Chimica dei Composti Organo Metallici ICCOM CNR Pisa, Italy)</dc:creator>
    </item>
    <item>
      <title>Fast decisions with biophysically constrained gene promoter architectures</title>
      <link>https://arxiv.org/abs/2507.03720</link>
      <description>arXiv:2507.03720v2 Announce Type: replace-cross 
Abstract: Cells integrate signals and make decisions about their future state in short amounts of time. A lot of theoretical effort has gone into asking how to best design gene regulatory circuits that fulfill a given function, yet little is known about the constraints that performing that function in a small amount of time imposes on circuit architectures. Using an optimization framework, we explore the properties of a class of promoter architectures that distinguish small differences in transcription factor concentrations under time constraints. We show that the full temporal trajectory of gene activity allows for faster decisions than its integrated activity represented by the total number of transcribed mRNA. The topology of promoter architectures that allow for rapidly distinguishing low transcription factor concentrations result in a low, shallow, and non cooperative response, while at high concentrations, the response is high and cooperative. In the presence of non-cognate ligands, networks with fast and accurate decision times need not be optimally selective, especially if discrimination is difficult. While optimal networks are generically out of equilibrium, the energy associated with that irreversibility is only modest, and negligible at small concentrations. Instead, our results highlight the crucial role of rate-limiting steps imposed by biophysical constraints.</description>
      <guid isPermaLink="false">oai:arXiv.org:2507.03720v2</guid>
      <category>q-bio.MN</category>
      <category>q-bio.SC</category>
      <pubDate>Wed, 08 Oct 2025 00:00:00 -0400</pubDate>
      <arxiv:announce_type>replace-cross</arxiv:announce_type>
      <dc:rights>http://arxiv.org/licenses/nonexclusive-distrib/1.0/</dc:rights>
      <dc:creator>Tarek Tohme, Massimo Vergassola, Thierry Mora, Aleksandra M. Walczak</dc:creator>
    </item>
  </channel>
</rss>
